MEDICAMEN BIOTECH LIMITED IS NOW NSE LISTED
WE ARE NOW NSE LISTED!
Medicamen Biotech Limited is now NSE LISTED
Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.
Poised to launch novel oncology products
Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.
Haridwar Unit 1 for formulations is WHO GMP approved
WHO GMP approved
Haridwar Unit 1 for formulations is WHO GMP approved
ANDA filing for oncology formulations in process
Abbreviated New Drug Application (ANDA) filing process
ANDA filing for oncology formulations in process
Who We Are
Corporate Overview
Infrastructure & Research
Formulation Facility
API Facility
Corporate R&D
What We Do
Therapeutic Focus
Products
Contact Info
Address Details
1506, Chiranjiv Tower, 43 Nehru Place, New Delhi - 110019 (India)
+91-11-47589500,
[email protected]
Daily: 9:00 am - 6:00 pm
Sunday: Closed